Stocks and Markets
"In the investing blog, I seek to help you take sound investment decisions free from emotion by sharing my
objective insights on markets, sectors, and companies."
The S&P 500 declined last week after additional economic relief from Congress remained stuck in neutral while suffering from the pandemic worsened.
The approval of a COVID-19 vaccine and hopes of additional financial aid from Congress helped the S&P 500 close the week at an all-time high.
If you are looking for the best growth stocks to buy now, this list of stodgy stalwarts from top sectors is worth checking. For one, all of them have strong near-term growth prospects. Second, some of them provide meaty dividends as well.
The S&P 500 declined last week as investors weighed rising COVID-19 infections and shutdowns against encouraging vaccine developments.
Although hopes of a COVID-19 vaccine and despair from rising COVID-19 cases swayed stocks, the S&P 500 closed the week at a record high.
The S&P 500 surged 7.2%, its biggest weekly gain since April. Democrat Biden was declared winner on Saturday, four days after the 2020 Presidential election.
The S&P 500 suffered its biggest weekly loss since March. Concerns of a contested presidential election and a return of lockdowns weighed on stocks.
Although U. S. companies topped earnings expectations, stocks broke their three-week uptrend on fading prospects of a new stimulus bill before the election.
The bulls and bears battled as impasse over stimulus and mixed COVID19-related news offset better-than-expected third quarter earnings.
U. S. stocks scored their biggest weekly percentage gain since July on optimism Congress will pass another stimulus package at least after the election.